Artificial intelligence (AI) software developer Qure.ai and Erasmus Medical Center in Rotterdam, the Netherlands, have launched a new AI research center.
Called the AI Innovation Centre for Medical Imaging, the program will initially perform research on AI-based detection of abnormalities for infectious and noninfectious disease conditions. The goal of the initiative is to understand potential use cases for AI in Europe and to provide guidance for clinicians on how to best adopt AI to meet their requirements, according to Qure.ai and Erasmus.
The research team will include multiple radiologists and doctoral students over the three-year partnership and will focus on the use of AI for chest CT, radiography, and brain CT exams.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
